The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorou…
When neurobiologist Elizabeth M. Adler was diagnosed with non-Hodgkin lymphoma almost twenty years ago, she learned everything she could about the disease, both to cope with the emotional stress of her diagnosis and to make the best possible decisions for her treatment. In "Livi…
Includes the latest information on lymphoma diagnosis, treatment, and incidence and describes recent updates to the WHO system of lymphoma classification and staging. The author discusses new targeted therapies like ibrutinib and idelalisib and describes how some treatments, inc…
